Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in SIGA — Siga Technologies Inc

CIK 1423053 MIAMI, FL
Back to SIGA Full portfolio

Position in SIGA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,006,535
-$1,765,947 QoQ
Shares Held
551,246
-21.8% QoQ
Ownership
0.767%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 161 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SIGA Over Time

Shares Held

Position Value (USD)

Derivatives in SIGA

reported options exposure · as of Dec 31, 2025
CallValue
$64,766
CallShares
10,600
PutValue
$91,650
PutShares
15,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,121,114 across 64 Drug Manufacturers - Specialty & Generic names. SIGA ranks #32 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 9,668,611 $237,944,516
2 ZTS
Zoetis Inc.
 3,188,263 $229,108,578
3 UTHR
UNITED THERAPEUTICS Corp
 304,692 $165,091,266
4 LNTH
Lantheus Holdings, Inc.
 1,376,480 $152,706,691
5 INDV
Indivior Pharmaceuticals, Inc.
 2,667,827 $109,460,941
6 ALKS
Alkermes plc.
 1,645,101 $86,203,291
7 SUPN
Supernus Pharmaceuticals, Inc.
 1,373,982 $63,903,902
8 HIMS
Hims & Hers Health, Inc.
 846,936 $29,363,271

All Filings in SIGA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,006,535 551,246
2026-03-31 $3,772,482 705,137
2025-12-31 $64,766 10,600
2025-12-31 $91,650 15,000
2025-12-31 $6,373,236 1,043,083
2025-09-30 $161,040 17,600
2025-09-30 $186,660 20,400
2025-09-30 $10,295,240 1,125,163
2025-06-30 $9,092,106 1,394,495
2025-06-30 $103,016 15,800
2025-06-30 $108,232 16,600
2025-03-31 $681,164 124,300
2025-03-31 $6,361,255 1,160,813
2025-03-31 $27,948 5,100
2024-12-31 $6,321,936 1,051,903
2024-12-31 $983,236 163,600
2024-12-31 $816,759 135,900
2024-09-30 $7,212,853 1,068,571
2024-09-30 $1,108,350 164,200
2024-09-30 $1,107,675 164,100
2024-06-30 $922,868 121,590
2024-06-30 $1,065,636 140,400
2024-06-30 $975,315 128,500
2024-03-31 $1,132,488 132,300
2024-03-31 $943,816 110,259
2024-03-31 $973,272 113,700
2023-12-31 $593,600 106,000
2023-12-31 $785,120 140,200
2023-12-31 $1,048,655 187,260
2023-09-30 $789,075 150,300
2023-09-30 $3,098,743 590,237
2023-09-30 $494,550 94,200
2023-06-30 $231,290 45,800
2023-06-30 $3,912,845 774,821
2023-06-30 $800,930 158,600
2023-03-31 $3,485,902 606,244
2023-03-31 $1,060,875 184,500
2023-03-31 $127,075 22,100
2022-12-31 $348,864 47,400
2022-12-31 $343,667 46,694
2022-12-31 $1,678,816 228,100
2022-09-30 $1,558,276 151,289
2022-09-30 $6,257,250 607,500
2022-09-30 $5,568,180 540,600
2022-06-30 $1,588,776 137,200
2022-06-30 $2,065,872 178,400
2022-03-31 $867,297 122,327
2021-12-31 $643,712 85,600
2021-12-31 $173,711 23,100
2021-12-31 $87,232 11,600

Report a Problem

Category
Description
Email (optional, for follow-up)